HBHuseyin Bozbas

Huseyin Bozbas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huseyin Bozbas has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Resolution of Lancisi’s sign following bicaval TricValve implantation for torrential tricuspid regurgitation: a case report defining a novel bedside marker of haemodynamic recovery

    by Mohamed Asfour, Huseyin Bozbas

    Background: Caval valve implantation (CAVI) using the TricValve system is an emerging treatment option for severe tricuspid regurgitation (TR) in patients who are unsuitable for surgery or orthotopic transcatheter intervention. Lancisi's sign is a classical manifestation of severe TR; however, its resolution after CAVI has not been described. Case summary: An 85-year-old woman with recurrent right heart failure and torrential TR presented with prominent bilateral Lancisi's sign. Echocardiography revealed severe annular dilatation (48 mm), right ventricular dysfunction (TAPSE, 13 mm), and a left ventricular ejection fraction of 40%. Owing to prohibitive surgical risk (EuroSCORE II 18.4%; TRI SCORE 14), she underwent successful implantation of 29-mm superior vena cava and 35-mm inferior vena cava TricValve prostheses. At 3 months, Lancisi's sign had completely resolved, NYHA functional class improved from III-IV to I-II, NT-proBNP decreased from 25 000 to 2 000 pg/mL, TAPSE increased from 13 to 20 mm, and no rehospitalization or device-related adverse event occurred. We report a structured single-patient case using clinical examination, echocardiography, invasive hemodynamic assessment, laboratory markers, and 3-month follow-up after bicaval TricValve implantation. Discussion: Bicaval TricValve implantation resulted in marked symptomatic, biochemical, echocardiographic, and bedside clinical improvements. The resolution of Lancisi's sign may represent a simple marker of hemodynamic recovery after CAVI.

  • Open Access

    Comparison of transcatheter aortic valve implantation and minimally invasive sutureless aortic valve replacement: A single-center study

    by Kivanc Atilgan, Huseyin Mmed Bozbas, Burak Emre Onuk, Burhan Kucuk, Zafer Cengiz Er, Tayfun Aybek

    This study aims to compare the clinical outcomes of isolated aortic valve replacement using a sutureless bioprosthetic valve (Perceval) and Transcatheter Aortic Valve Implantation (TAVI). This single-center retrospective study evaluated 143 patients who underwent isolated surgical minimally invasive aortic valve replacement and TAVI procedures between January 2020 and February 2025. Demographic, intraoperative, and postoperative data as well as perioperative echocardiographic findings were analyzed and compared. The patients were divided into 2 groups: Sutureless (n = 73) and TAVI (n = 70). The Intensive care unit stay, intubation time, and hospital discharge time were significantly shorter in the TAVI group ( P < .05). The requirement for inotropic support was also lower (2.8% vs 24.1%, P < .001). At the 30-day follow-up, the TAVI group had significantly lower mean and maximum transvalvular gradient. The need for pacemaker implantation was significantly higher in the TAVI group ( P = .001). Pacemakers were implanted in 1.4% of patients in the sutureless group and 17.1% of patients in the TAVI group. The sutureless group had a significantly longer mean discharge time (5.47 ± 2.86 days) compared to the TAVI group (3.89 ± 2.93 days; P = .001). Similarly, intubation time was significantly longer in the sutureless group (11.90 ± 5.84 hours) compared to the TAVI group (3.37 ± 19.17 hours; P = .001). TAVI is a safe and effective alternative in appropriately selected patients, offering shorter operative times and improved early postprocedural recovery without compromising clinical or hemodynamic outcomes.

  • Combined Transcatheter Edge-to-Edge Repair in Different Mitral and Tricuspid Regurgitation Combinations: A Contemporary and Comprehensive Review. Concomitant or Staged Procedure?

    by Hüseyin Bozbaş, Zeynettin Kaya, Erdoğan İlkay

    Transcatheter edge-to-edge repair (TEER) has become an effective treatment option for mitral regurgitation (MR) and tricuspid regurgitation (TR), with high procedural success and low complication rates. Moderate-to-severe MR and TR coexist in approximately 11% of patients with heart failure, and patients with both conditions have a worse prognosis than those with either lesion alone. Current guidelines recommend treatment of concomitant TR during mitral valve surgery when tricuspid annular dilation is present. However, there are no clear recommendations for combined TEER, as mitral and tricuspid TEER are addressed separately in the guidelines. In this review, the available evidence and current clinical approaches to combined vs. isolated TEER across different combinations and severities of MR and TR were evaluated.

  • Tricuspid Valve-in-Valve Procedure: What to Do When the Bioprosthetic Valve Is Not Visible on Fluoroscopy? Challenges and Step-by-Step Description of the Procedure

    by Hüseyin Bozbaş

    The main disadvantage of bioprosthetic heart valves is their potential for degeneration in the medium to long term. Due to the high risk associated with reoperation, the percutaneous valve-in-valve (ViV) approach is preferred for patients with bioprosthetic degeneration following tricuspid valve replacement. However, the procedure can be challenging when the implanted bioprosthetic valve is not radio-opaque. We present three cases performed at our hospital, detailing a step-by-step approach and alignment techniques when the valve is not visible on fluoroscopy. All patients were admitted with right heart failure and demonstrated severe dysfunction of their tricuspid bioprosthetic valves. In the first case, the bioprosthetic valve was clearly visible on fluoroscopy, which facilitated the alignment process. In the other two cases, the valves were not visible. Predilation was performed, and the resulting indentation line served as a reference. Echocardiographic (ECHO) imaging, along with right atrial and ventricular angiograms, was used to guide the alignment of the balloon-expandable valve. The ViV procedure was successful in all three cases. The transcatheter ViV approach appears to be an effective treatment option for patients with tricuspid bioprosthetic valve degeneration. In cases where the valve is not radio-opaque, the procedure can be safely performed by using the indentation point from balloon dilatation, right ventricular and atrial angiography, and transthoracic or transesophageal echocardiography to guide valve alignment.

  • Open Access

    Caval Valve Implantation Procedure in 7 Cases of Torrential Tricuspid Regurgitation and Step-by-Step Description of the Procedure

    by Hüseyin Bozbaş, Cem Barçın, Mohamed Asfour, Savaş A. Çelebi, Ersin Çam, Erdoğan İlkay


  • Percutaneous Mitral Valve-in-Ring Procedure in a Case of Severe Mitral Regurgitation Repaired with a Surgical Flexible Ring: A Step-by-Step Description

    by Hüseyin Bozbaş

    Severe mitral regurgitation (MR) following surgical repair of the mitral valve poses a significant clinical challenge. Patients who have undergone surgery are typically at high risk for a second operation. This report details the case of a 54-year-old male who underwent aortic valve replacement and mitral valve repair using a 34-ring, 14 years prior. The patient presented with severe MR, severe left ventricular (LV) dilation, and a reduced ejection fraction of 20%. A Sovering 34 ring, characterized by its oval, radio-opaque, and flexible nature and completely encircling the annulus, was used. After comprehensive assessment utilizing cardiac computed tomography (CT) and the Valve-in-Valve (ViV) application, a 32 mm balloon-expandable transcatheter heart valve was chosen. The selected valve was the 32 mm Myval (Meril) valve, the largest size available globally. Following careful alignment (left atrium/left ventricle ratio (LA/LV) ratio 20/80) and under rapid pacing, the valve was successfully implanted within the ring. Subsequent transesophageal echocardiography confirmed the valve's functionality, and left ventriculography showed no paravalvular regurgitation. The Mitral Valve-in-Ring (MVIR) procedure emerges as a promising therapeutic option for patients with a history of mitral valve repair and severe MR. This procedure is preferred in centers where structural heart interventions are performed by an experienced team.

  • Open Access

    Remote patient monitoring after cardiac surgery: The utility of a novel telemedicine system

    by Kıvanç Atilgan, Burak E. Onuk, Pınar Köksal Coşkun, Fahri G. Yeşi̇l, Cemal Aslan, Abdullah Çolak, Aksüyek S. Çelebi̇, Hüseyin Bozbaş

    Objective We examined cardiac surgery patients who underwent monitoring of postoperative vital parameters using medical monitoring devices which transferred data to a mobile application and a web-based software. Methods From November 2017 to November 2020, a total of 2340 patients were enrolled in the remote patient monitoring system after undergoing cardiac surgery. The medical devices recorded vital parameters, such as blood pressure, pulse rate, saturation, body temperature, blood glucose, and electrocardiography were measured via the Health Monitor DakikApp and Holter ECG DakikApp devices which reported data to web-based software and a mobile application (DakikApp Mobile Systems, Remscheid, Germany). During the follow-up period, patients were contacted daily through text and voice messages, and video conferences. Remote Medical Evaluations (RMEs) concerning patients' medical states were performed. Medication reminders, daily treatment were communicated to the patients with the DakikApp Mobile Systems Software. Results During a mean follow-up period of 78.9 ± 107.1 (10–395) days, a total of 135,786 patient contacts were recorded (782 video conferences, 2805 voice messaging, and 132,199 text correspondence). The number of RMEs handled by the Telemedicine Team was 79,560. A total of 105,335 vital parameter measurements were performed and 5024 hospital application requests (6.3% per RME) were addressed successfully and hospitalization was avoided. A total of 144 (6.1%) potentially life-threatening complications were found to have been diagnosed early using the Telemedicine System. Conclusion Remote Patient Monitoring Systems combined with professional medical devices are feasible, effective, and safe for the purpose of improving postoperative outcomes.


  • Open Access

    Value of cardiopulmonary exercise testing in the diagnosis of coronary artery disease

    by Berna Akinci Özyürek, Şerife Savaş Bozbaş, Alp Aydinalp, Hüseyin Bozbaş, Gaye Ulubay

    Respiratory and cardiac functions in association with skeletal and neurophysiologic systems can be evaluated with cardiopulmonary exercise testing (CPET). Compared to treadmill exercise test, CPET provides more comprehensive data about the hemodynamic response to exercise. We aimed to evaluate the relationship with CPET findings and coronary lesions identified on angiography in patients with angina pectoris who underwent teradmill exercise, CPET and coronary angiography (CAG). By this way we sought to examine the CPET parameters that might be predictive for coronary artery disease (CAD) before diagnostic exercise test results and ischemia symptoms develop. Thirty patients in whom CAG was planned because of symptoms and exercise test results were enrolled in the study. Oxygen consumption (VO2), carbondioxide production (VCO2), minute ventilation (VE), maximum work rate (WR), DVO2/DWR and O2 pulse (VO2/HR) values were calculated. Significant CAD was defined as ≥ 50% narrowing in at least one of the coronary arteries. The mean age was 60.4 ± 8.9 years ve 21 (65.6%) of subjects were male. On CAG, CAD was detected in 19 (59.4%) patients. Maximum heart rate, heart rate reserve (HRR), VE/VCO2 measured at anaerobic threshold (AT) and VO2(mL/kg/min) were significantly differed in patients with CAD than those without (p= 0.031; p= 0.041; p= 0.028; p= 0.03 respectively). Peak VO2, VO2/WR and O2 pulse values were higher in patients with normal angiographic results than those with CAD but the difference did not reach to statistical significance. The findings of our study indicate that among CPET parameters AT VE/VCO2, ATVO2 (mL/kg/dk) and HRR can have predictive value in the diagnosis of CAD. We think that these parameters might be used in the evaluation of patients with angina and dyspnea suspected of CAD. In conclusion parameters obtained during the test that are not influenced by patient's effort might increase the value of CPET in the diagnosis CAD.